Alcon, CH0432492467

Systane Ultra eye drops by Alcon Inc. - dry-eye relief backed by a broad product family

Veröffentlicht: 11.07.2026 um 16:00 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

Systane Ultra eye drops land in the eye as a thin, cool film and target dry-eye symptoms in everyday screen use. This product is driving the price of Alcon Inc. stock (ISIN CH0432492467).

Alcon, CH0432492467, Illustration mit AI erstellt.
Alcon, CH0432492467, Illustration mit AI erstellt.

Systane Ultra eye drops hit the eye as a cool, almost silky film when you tilt your head back and squeeze the small plastic bottle for a single drop. In clinics, ophthalmologist Dr. Maria Keller jokes that half her waiting room has a Systane bottle in their bag already.

Formulation built for dry eyes

Alcon Inc. positions Systane Ultra as a lubricating eye drop for people with dry-eye symptoms such as burning, irritation or a gritty feeling, especially after long periods at digital screens. The formulation uses polyethylene glycol and propylene glycol as active lubricants in a HP?guar based matrix to stabilize the tear film.

The drops are designed to mimic parts of the natural tear layer, helping reduce friction when the eyelid moves over the cornea. One drop typically provides several hours of comfort for mild to moderate dry eye, according to product information and clinical data Alcon summarizes in its professional materials.

Dig deeper & contextualize

Alcon dry-eye franchise in focus

How the Systane line supports Alcon Inc. revenues and shapes competition in the global dry-eye market.

Dosing, variants and everyday use

On the Systane website, Alcon recommends instilling one or two drops into the affected eye as needed during the day, and blinking a few times to spread the liquid across the surface. Regular users often keep a bottle at their desk to counteract air conditioning and screen exposure.

Systane Ultra sits in a larger family that includes Systane Complete, Systane Hydration and preservative-free single-use vials. The Ultra variant targets patients who need more intensive lubrication than classic artificial tears but do not yet require prescription dry-eye drugs.

Packaging, preservatives and safety profile

In Germany and other European markets, Systane Ultra is usually sold as a multi-dose bottle with 10 ml of solution, fitted with a small dropper tip that feels firm but not sharp against the eyelid margin. The liquid itself is clear and slightly viscous compared with plain saline.

The eye drops contain the preservative POLYQUAD (polyquaternium?1), which Alcon highlights as a gentler alternative to benzalkonium chloride in long-term dry-eye use. Many ophthalmologists still prefer preservative-free single-dose vials for very sensitive patients, but consider Systane Ultra acceptable for broad chronic use.

Regulatory status and availability

Alcon markets Systane Ultra in Europe as a medical device in the lubricating eye drop class, and as an over-the-counter product in the United States. That means consumers typically buy it without a prescription in pharmacies, optical shops or online retailers.

In Germany, Systane Ultra is widely listed on pharmacy e-commerce sites and optical chains, while some hospital pharmacies stock larger quantities for post-surgery patients. The company’s distribution reach benefits from its long-standing relationships with ophthalmology practices and surgical centers built through its intraocular lens and equipment business.

Pricing and competition

Street prices in Germany for a 10 ml Systane Ultra bottle often cluster between 10 and 15 Euro, depending on the pharmacy and any promotions for multi-pack offers. In the US, a comparable bottle typically retails around USD 15 to 20 in big-box stores and drugstore chains.

That pricing puts Systane Ultra in the branded tier above no-name artificial tears, but roughly in line with other specialist brands such as Allergan’s Refresh drops and Johnson & Johnson’s Blink line. Retail pharmacists say patients often trade up to Systane based on specialist recommendations from their ophthalmologist rather than price alone.

Clinical positioning and patient profiles

In professional materials, Alcon presents data indicating that Systane Ultra improves tear-film stability and reduces corneal staining in patients with dry-eye disease compared with baseline artificial tear use. These studies usually measure objective markers such as break-up time and fluorescein staining alongside patient-reported comfort.

Ophthalmologists like Dr. Keller use Systane Ultra as a first-line or second-line option for office workers, contact-lens wearers and older adults with age-related tear deficiency. Patients often describe the sensation as slightly thicker and "cushioned" compared with standard saline-based drops, which can feel watery and short-lived.

Role in Alcon’s broader portfolio

Under CEO David Endicott, Alcon has invested heavily in the dry-eye category, using Systane as its consumer-facing anchor brand while expanding diagnostics and in-office treatments. Systane Ultra acts as a core SKU that keeps the brand visible on pharmacy shelves and in ophthalmology waiting rooms.

Analysts covering Alcon emphasize that dry-eye products provide recurring revenue that is less cyclical than surgical equipment sales. The Systane line therefore functions as a stabilizing pillar in the company’s mix, even if any single variant like Ultra does not dominate the portfolio on its own.

Context for retail investors

For retail investors, Systane Ultra illustrates how a seemingly simple bottle of eye drops plugs into a larger strategy: recurring sales, brand loyalty among ophthalmologists, and a ladder of increasingly specialized dry-eye products. In the competitive eye-care market, this segment supports the price of Alcon Inc. stock (ISIN CH0432492467).

Key data on Systane Ultra

  • Product: Systane Ultra eye drops
  • Manufacturer: Alcon Inc.
  • Category: B2B/Pro line (eye-care, medical device)
  • Market launch: Systane Ultra has been available in major markets for over a decade, with ongoing line updates.
  • MSRP / Price: Typically around 10–15 EUR for 10 ml in Germany; roughly USD 15–20 in the US, depending on retailer.
  • Availability: Over the counter in pharmacies, optical shops and online; no prescription required in core markets.
  • Target group: Adults with dry-eye symptoms from screen use, aging, contact lenses or environmental factors.
  • Highlight / USP: Lubricating HP?guar formulation with polyethylene glycol and propylene glycol, designed to stabilize the tear film and provide longer-lasting comfort than standard artificial tears.

Find more on Systane Ultra

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | CH0432492467 | ALCON | boerse | 69745403 | bgmi